APA (7th ed.) Citation

Liu, D., & Hofman, P. (2022). Expression of NOTCH1, NOTCH4, HLA-DMA and HLA-DRA is synergistically associated with T cell exclusion, immune checkpoint blockade efficacy and recurrence risk in ER-negative breast cancer. Cellular Oncology (2211-3428), 45(3), 463. https://doi.org/10.1007/s13402-022-00677-6

Chicago Style (17th ed.) Citation

Liu, Dingxie, and Paul Hofman. "Expression of NOTCH1, NOTCH4, HLA-DMA and HLA-DRA Is Synergistically Associated with T Cell Exclusion, Immune Checkpoint Blockade Efficacy and Recurrence Risk in ER-negative Breast Cancer." Cellular Oncology (2211-3428) 45, no. 3 (2022): 463. https://doi.org/10.1007/s13402-022-00677-6.

MLA (9th ed.) Citation

Liu, Dingxie, and Paul Hofman. "Expression of NOTCH1, NOTCH4, HLA-DMA and HLA-DRA Is Synergistically Associated with T Cell Exclusion, Immune Checkpoint Blockade Efficacy and Recurrence Risk in ER-negative Breast Cancer." Cellular Oncology (2211-3428), vol. 45, no. 3, 2022, p. 463, https://doi.org/10.1007/s13402-022-00677-6.